Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients.

@article{L2005DermalLE,
  title={Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients.},
  author={Monique G. L{\^e} and Rodrigo A Arriagada and Gen{\`e}vieve Contesso and Mohamed Cammoun and Fr{\'e}d{\'e}rique Pfeiffer and Françoise Tabbane and Jacqueline Bahi and Mich{\`e}le Dilaj and Marc Spielmann and Jean-Paul Travagli and Thomas Tursz and Nejib Mourali},
  journal={Clinical breast cancer},
  year={2005},
  volume={6 5},
  pages={
          439-45
        }
}
BACKGROUND We studied whether dermal lymphatic emboli (DLE) add independent prognostic information to the clinical definition of inflammatory breast cancer (IBC). PATIENTS AND METHODS The study was performed in 2 centers, one each in France and Tunisia. For every patient with IBC, 1-3 patients with noninflammatory breast cancer (non-IBC) were included. All patients were to have a surgical tumor biopsy, including a sample of the skin surrounding the tumor. The endpoint was the risk of a… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations